AI in Journal Workflows: Streamlining or Sidetracking?

The American Cancer Society is turning heads with its integration of AI to automate processes in its peer-reviewed journal workflow. This move is part of a broader trend in scientific publishing, where AI promises faster and more efficient operations. But is it really all it's cracked up to be?

A Cutting Edge or a Double-Edged Sword?

The American Cancer Society isn't alone. Journals across the globe are eyeing automation to expedite peer review, manage submissions, and handle administrative tasks. This sounds like a win for productivity. But ask the workers, not the executives, and you might hear a different story.

Automation isn't neutral. It has winners and losers. While AI can zip through repetitive tasks, it also risks sidelining the human expertise that ensures quality and integrity. Where's the line between efficiency and compromise?

Lessons from the Front Line

The Society's journey hasn't been bump-free. Lessons learned include the need for clear communication and training to mitigate initial confusion and resistance. Retraining staff to work alongside AI has been important. Yet, the productivity gains went somewhere. Not to wages, but to bottom lines.

The push for AI in journals is a reminder of automation's dual nature. It's not just about speeding up processes. It's about who pays the cost when machines start doing what humans once did. The jobs numbers tell one story. The paychecks tell another.

What’s the Real Goal?

Sure, faster reviews mean new research hits the public domain quicker. That's undeniably positive. But are we prioritizing speed over thoroughness? In an industry where accuracy literally saves lives, it's.

AI's impact on the labor market is unavoidable. The American Cancer Society might find its workflow smoother, but it's imperative to ask whether the human side of the equation is getting the attention it deserves. The risk of displacing skilled workers should keep us questioning the real goals behind AI integration.